This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

  • Scientist in laboratory

    Latest Article

    Alternative complement pathway inhibition with iptacopan in IgA nephropathy

    IgA nephropathy is the commonest glomerulonephritis in the Western world. Nephrologists know this, but it is a sentence that has been drilled into my conscio...

  • Pills being tipped into a hand

    Iptacopan in IgA nephropathy

  • Patient in a consultation

    PARAGON-HF: Kidney function and cardiovascular outcomes with sacubitril/valsartan

  • Heart concept image

    BARACK-D: low-dose spironolactone and cardiovascular outcomes in moderate CKD

  • Rack of blood sample tubes

    Do we fully understand the risk factors associated with venous thromboembolism in nephrotic syndrome?

  • Risk of thromboembolic events in patients with nephrotic syndrome and relatively high albumin levels

  • Effects of heart failure therapies on standardised kidney outcomes

Show all articles >
alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe